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Hair loss, as it occurs with telogen efﬂuvium and androgenetic alopecia, provokes anxieties and distress more
profound than its objective severity would appear to justify. This reﬂects the profound symbolic and psychosocial
importance of hair. Stress has long been implicated as one of the causal factors involved in hair loss. Recently,
in vivo studies in mice have substantiated the long-held popular belief that stress can exert profound hair growth-
inhibitory catagen-inducing and hair-damaging pro-inﬂammatory effects. Insights into the negative impact of
stress on hair growth and the integration of stress-coping strategies into the management of hair loss disorders as
well as the development of new pharmacotherapeutic strategies might lead to enhanced therapeutic modalities
with the alleviation of clinical symptoms as well as the concomitant psychological implications.
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Although a benign medical condition, affected individuals
experience great psycho-emotional stress, often leading to
a reduction of quality of life and secondary morbidity. Some
patients’ suffering can reach a level where the burden of hair
loss is comparable with that caused by many more severe
chronic or life-threatening diseases (de Koning et al, 1990;
Cash, 2001).
In recent years, correlations between specific coping
strategies and quality of life have emerged. Particularly, the
development of better instruments for assessing quality of
life has allowed identification and intervention of coping
patterns (Table II) (Schmidt et al, 2001).
Stress has long been implicated as one of the causal
factors involved in hair loss (Bosse and Gieler, 1987; Paus,
2000; Botchkarev, 2003). With respect to the connections
between psycho-emotional stress and hair loss, several
levels of interactions can be distinguished: (a) acute or
chronic stress as a primary inducer of telogen effluvium, (b)
acute or chronic stress as an aggravating factor in a hair
loss disorder whose primary pathogenesis is of endocrine,
toxic, metabolic or immunological nature (e.g. AGA, alo-
pecia areata), and (c) stress as a secondary problem in re-
sponse to prior hair loss. The latter might also contribute to
the perpetuation or aggravation of hair loss and induce a
self-perpetuating vicious circle (Fig 1).
Recent studies in mice have substantiated the long-held
popular belief that stress can exert profound hair growth-
inhibitory catagen-inducing and hair-damaging pro-inflam-
matory effects, with a likely key role for substance P (SP)
(Arck et al, 2001, 2003) (Fig S1, see full-text version online)
and corticotrophin releasing hormone (Aoki et al, 2003). If
transferable to the human system, the stress effects eluci-
dated for murine hair follicles would result in a marked telo-
gen effluvium under clinical conditions. Administration of a
Table I. Patient-perceived negative effects of hair lossa
 Shame  Feeling uncomfortable
 Anger  Dissatisfaction with body image
 Embarrassment  Feeling of being older
 Humiliation  Sense of inadequacy
 Disgrace  Loss of self-confidence
 Hate  Unhappy about appearance
 Disgust  Reduced worth
 Fright  Reduced social acceptance
 Sadness  Feelings of helplessness
 Depression  Self-consciousness
 Worrying  Social stress
 Frustration  Powerlessness
aModified after van der Donk et al (1991) Cash et al (1993), Franzol et al
(1990), and Girman et al (1999).
Table II. Coping strategies for diffuse and androgenetic
alopeciaa
Pro-adaptive Mal-adaptive
 Flexible coping: positive
and constructive
 Hair focused coping
(hair-speciﬁc
dysmorphophobia):
social withdrawal, anger
towards others, aimless
reflection on hair loss
 Bother minimizing:
diversion, optimism, denial,
acceptance, stoicism
 Negative emotional:
resignation, brooding,
anxiety, self-accusation
aModified after Schmidt et al (2001).
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specific SP receptor (NK 1) antagonist can abrogate the
stress-induced hair-growth-inhibiting or hair follicle-damag-
ing effects in mice (Arck et al, 2001, 2003).
Stress-induced hair growth inhibition is promoted by
nervegrowth factor (NGF) which appears to be up-stream of
SP (Peters et al, 2004). These findings are noteworthy in two
respects: They have identified missing molecular links be-
tween psycho-emotional stressors and well-defined param-
eters that reflect hair follicle growth and function—the
neuropeptide SP and the neurotrophin NGF. In addition, the
finding that an NK1 antagonist could counteract most of the
stress-induced negative effects on the hair follicle is partic-
ularly intriguing since NK1 antagonists are under clinical
investigation as a potential new class of anti-depressive
drugs (Rupniak and Kramer, 1999). Therefore, it is tempting
to speculate that NK1 antagonists might be especially well-
suited to inhibit the adverse hair growth effects of psycho-
emotional stress at the basis of the underlying molecular
pathogenesis chain, while at the same time offering helpful
pharmacotherapeutic support to allow affected patients
with hair loss to break away from the depressing pyscho-
and socio-dynamic vicious circles of hair loss (Fig 1).
Besides SP, a plethora of other stimuli and mediators
(neurotransmitters, neuropeptides, neurohormones, neu-
rotrophins, etc.) must now be considered as potential local
or systemic mediators of stress-induced hair growth inhi-
bition—not the least since the hair follicle has been iden-
tified as both a prominent peripheral target organ and a
source for many bioregulatory molecules recognized as
mediators of stress responses (Paus and Cotsarelis, 1999;
Paus, 2000, 2001; Arck et al, 2001, 2003; Botchkarev 2003;
Peters et al, 2004). For example, in mice and/or man, hair
follicle cycling, whose alteration lies at the basis of telogen
effluvium (Paus and Cotsarelis, 1999), is modulated by
catecholamins, prolactin, and nerve growth factor, three
classical bioregulators of systemic stress responses. Stress
responses, mediated by typical stress hormones, like cat-
echolamines, prolactin, ACTH, CRH, b-endorphins, gluco-
corticoids, and SP, directly and indirectly may alter hair
growth by interacting and disturbing the release of the
various neuropeptides (Paus, 1999; Slominski et al, 1999,
2000; Botchkarev, 2003). Also, the hair follicle itself can
generate an abundance of stress mediators and expresses
cognate receptors and thus may directly be involved in the
modulation of stress responses at the local level, possibly
as part of a ‘‘skin stress system’’ (Slominski et al, 2000).
Recently, it has also become apparent that inflammatory
stimuli, especially agents involved in neurogenic inflamma-
tion, may play an important role in hair growth modulation
(Paus, 1999; Ru¨ckert et al, 2000; Arck et al, 2001, 2003;
Botchkarev, 2003). Although further investigation is required
to fully elucidate the interactions of these factors in human
hair follicle biology, as well as the impact of psycho-emo-
tional stress (acute and chronic) on the release of neuro-
peptides and their effects on human hair growth, these
stimuli should now be considered when discussing strate-
gies for the management of hair loss.
No specific pharmacological intervention is currently
available to manage stress-induced hair loss in man. An
effective therapeutic intervention in this respect would have
to prolong the anagen phase of the hair cycle, thus pre-
venting the premature onset of catagen, which forms the
basis of stress-induced telogen effluvium (Paus and Cots-
arelis, 1999). Topical minoxidil (MXL) may be considered
a reasonable candidate drug for the management of stress-
related hair loss since it is known to prolong anagen (Buhl,
1989). Also, recent results from a well-established mouse
model on stress-induced hair loss demonstrate that most of
the stress-induced hair growth-inhibitory changes along the
‘‘brain–hair axis’’ (Arck et al, 2001), including premature hair
cycle progression towards catagen, could be downregulat-
ed by topical MXL application (Arck et al, 2003a). Whether
MXL is also capable of counteracting negative effects of
‘‘stress’’ on human hair growth remains to be investigated.
Insights into the negative impact of stress on hair growth
particularly encourage one to integrate stress-coping strat-
egies into the management of hair loss disorders and to
therapeutically interfere with the stress-aggravating factors
indicated in Fig 1. Hair loss patients, therefore, require com-
plex, comprehensive and careful management beyond drug
prescription in order to alleviate their clinical symptoms and
the concomitant psychological implications.
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